| ²é¿´: 943 | »Ø¸´: 3 | |||
ºì¹û¹û74Òø³æ (СÓÐÃûÆø)
|
[½»Á÷]
һƪ¹ØÓÚ²¡¶¾Ñù¿ÅÁ£ÒßÃçµÄÎÄÕÂͶ¸åÓÚJ virol±à¼µÄÒâ¼ûÎÒ¼«¶È²»Âú ÒÑÓÐ2È˲ÎÓë
|
|
±à¼ÕâÑù˵£º I have looked over your paper carefully and discussed with another Senior Editor who is an expert in the vaccine field. Both of us agree that while the work is well-executed, it is a relatively incremental advance given the prior use of FMDV VLPs, and thus is better suited to a more specialized Vaccine journal. I am sorry to convey a negative decision on this occasion. J virolÉÏ·¢±íÁ˹ØÓÚµÄÒßÃçÒÔ¼°ÒßÃçÃâÒßЧ¹ûµÄÎÄÕ£¬¼´Ê¹×îÐµļ¸ÆÚÉÏÒ²Óкü¸Æª¡£ÎÒÊDz»ÊÇ¿ÉÒԺͱà¼ÔÙargueһϣ¿ÓгæÓÑÖªµÀÕâÑù»áÓÐЧ¹ûÂ𣿻¹ÓÐʲôÏàͬˮƽµÄÆÚ¿¯¿ÉÒÔͶ£¿Ï£Íû°ïÎÒ³ö¸öÖ÷Ò⡣лл¸÷λÁË¡£ |
» ²ÂÄãϲ»¶
271Çóµ÷¼Á
ÒѾÓÐ37È˻ظ´
²ÄÁϹ¤³Ì281»¹Óе÷¼Á»ú»áÂð
ÒѾÓÐ34È˻ظ´
279Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏÏà¹Ø×¨Òµ344Çóµ÷¼ÁË«·Ç¹¤¿ÆÑ§Ð£»ò¿ÎÌâ×é
ÒѾÓÐ17È˻ظ´
»¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô
ÒѾÓÐ27È˻ظ´
»¯Ñ§070300 Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
085801µçÆø×¨Ë¶272Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
085600²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ17È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
¹ØÓÚ»¯Ñ§·¢¹âÎÄÕµÄͶ¸å
ÒѾÓÐ4È˻ظ´
Antiviral Research Çó´óÏÀÖ¸µãÒ»ÏÂ
ÒѾÓÐ3È˻ظ´
PMSͶ¸å±à¼³õÉóÒâ¼û
ÒѾÓÐ4È˻ظ´
timegardener
Òø³æ (ÕýʽдÊÖ)
- SEPI: 1
- Ó¦Öú: 91 (³õÖÐÉú)
- ½ð±Ò: 1102.6
- É¢½ð: 1000
- ºì»¨: 14
- Ìû×Ó: 457
- ÔÚÏß: 168.4Сʱ
- ³æºÅ: 1452780
- ×¢²á: 2011-10-20
- ÐÔ±ð: GG
- רҵ: »·¾³Î¢ÉúÎïѧ

2Â¥2012-09-02 05:49:16
¶À²½ÇàÔÆ
гæ (Ö°Òµ×÷¼Ò)
ÊõÖÐСÉú
- Ó¦Öú: 894 (²©ºó)
- ½ð±Ò: 2993.1
- É¢½ð: 3834
- ºì»¨: 16
- Ìû×Ó: 3587
- ÔÚÏß: 241.8Сʱ
- ³æºÅ: 339818
- ×¢²á: 2007-04-07
- ÐÔ±ð: GG
- רҵ: ÖÐÒ©ÖÊÁ¿ÆÀ¼Û
3Â¥2012-09-02 07:06:12
ºì¹û¹û74
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 1052.2
- ºì»¨: 1
- Ìû×Ó: 113
- ÔÚÏß: 46.3Сʱ
- ³æºÅ: 1548985
- ×¢²á: 2011-12-23
- רҵ: ÊÞÒ½´«È¾²¡Ñ§
| лл¸÷λµÄÒâ¼û£¬ÎÒÕâÆªÎÄÕµÄÖÊÁ¿Ó¦¸ÃÊDZȽϸߵ쬶øÇÒÑо¿¹ý³ÌÀúʱÁ½Äê¶à£¬Éæ¼°Ê®¼¸¸öÈ˲ÎÓ루ÒòΪҪ×öëàÊó¡¢Öí¡¢Å£µÄÃâÒßʵÑ飩£¬ËùÒÔ£¬Ò»Ö±¶¼½«Ä¿±ê·ÅÔÚJVÉÏ£¬Èç¹û¸ÄͶÆäËûÔÓÖ¾£¬»¹Õæ²»ÖªµÀ¸ÃͶÄǸöͬµÈˮƽµÄÏà¹ØÆÚ¿¯ÁË¡£ |
4Â¥2012-09-02 09:05:01














»Ø¸´´ËÂ¥